De novo terminal deletion of 11q [del(11)(q24.2)]

被引：0
|
作者：
Pappas, JG [1 ]
Sadiq, A [1 ]
Bhatt, J [1 ]
Babu, A [1 ]
Penchaszadeh, VB [1 ]
机构：
[1] Beth Israel Med Ctr, Div Med Genet, New York, NY 10003 USA
来源：
EUROPEAN JOURNAL OF HUMAN GENETICS | 1998年 / 6卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P2101
引用
收藏
页码：95 / 95
页数：1
相关论文
共 50 条
  • [41] Terminal Deletion of 11q with Significant Late-Onset Combined Immune Deficiency
    Seppanen, Mikko
    Koillinen, Hannele
    Mustjoki, Satu
    Tomi, Molkanen
    Sullivan, Kathleen E.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 (01) : 114 - 118
  • [42] PARTIAL DELETION 11Q - REPORT OF A CASE WITH A LARGE TERMINAL DELETION 11Q21-QTER WITHOUT LOSS OF TELOMERIC SEQUENCES, AND REVIEW OF THE LITERATURE
    HERTZ, JM
    TOMMERUP, N
    SORENSEN, FB
    HENRIQUES, UV
    NIELSEN, A
    THERKELSEN, AJ
    CLINICAL GENETICS, 1995, 47 (05) : 231 - 235
  • [43] Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone (vol 31, pg 88, 2013)
    Marasca, Roberto
    Maffei, Rossana
    Martinelli, Silvia
    Fiorcari, Stefania
    Bulgarelli, Jenny
    Debbia, Giulia
    Rossi, Davide
    Rossi, Francesca Maria
    Rigolin, Gian Matteo
    Martinelli, Sara
    Gattei, Valter
    Del Poeta, Giovanni
    Laurenti, Luca
    Forconi, Francesco
    Montillo, Marco
    Gaidano, Gianluca
    Luppi, Mario
    HEMATOLOGICAL ONCOLOGY, 2013, 31 (03) : 168 - 168
  • [44] CLINICAL IMPACT OF DEL (11Q) IN PATIENTS WITH DE NOVO AND SECONDARY MYELODYSPLASTIC SYNDROMES- A SINGLE INSTITUTION EXPERIENCE
    Alkhateeb, H.
    Damlaj, M.
    Al-Kali, A.
    Gangat, N.
    Begna, K. H.
    Litzow, M. R.
    Hogan, W. J.
    Elliott, M. A.
    Ketterling, R. P.
    Patnaik, M. S.
    HAEMATOLOGICA, 2015, 100 : 241 - 241
  • [45] Partial trisomy 11q syndrome (11q23.1→11qter) due to de novot (11q;13q) detected by multicolor fluorescence in situ hybridisation
    Utine, GE
    Thoelen, R
    Peeters, H
    Vermeesch, J
    Fryns, JP
    GENETIC COUNSELING, 2005, 16 (03): : 291 - 295
  • [46] A CASE WITH BALANCED RECIPROCAL TRANSLOCATION t(5;11)(q32;q24.2) AND SITUS INVERSUS VISCERUM
    Karaman, A.
    Binici, D. N.
    Gunes, N.
    Doru, I.
    Kabalar, M. E.
    Kurt, A.
    GENETIC COUNSELING, 2010, 21 (02): : 237 - 242
  • [47] Myelodysplastic neoplasm with del(11q). Rara Avis.
    Gale, Robert Peter
    LEUKEMIA RESEARCH, 2025, 150
  • [48] ASSIGNMENT OF HUMAN PORPHOBILINOGEN DEAMINASE TO 11Q24.1-]Q24.2 BY INSITU HYBRIDIZATION AND GENE DOSAGE STUDIES
    NAMBA, H
    NARAHARA, K
    TSUJI, K
    YOKOYAMA, Y
    SEINO, Y
    CYTOGENETICS AND CELL GENETICS, 1991, 57 (2-3): : 105 - 108
  • [49] TERMINAL DELETION 6q SYNDROME WITH 11q PARTIAL TRISOMY MOSAICISM DUE TO MATERNAL BALANCED TRANSLOCATION
    Imataka, G.
    Okuya, M.
    Hirao, J.
    Arisaka, O.
    GENETIC COUNSELING, 2014, 25 (01): : 63 - 67
  • [50] 11q deletion in neuroblastoma: a review of biological and clinical implications
    Mlakar, Vid
    Mlakar, Simona Jurkovic
    Lopez, Gonzalo
    Maris, John M.
    Ansari, Marc
    Gumy-Pause, Fabienne
    MOLECULAR CANCER, 2017, 16
12345